Items where authors include "Horton, S."
Article
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370
Borrego-Yaniz, G., Ortiz-Fernández, L., Madrid-Paredes, A. et al. (291 more authors) (2024) Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study. The Lancet Rheumatology, 6 (6). e374-e383. ISSN 2665-9913
Lyon, M. orcid.org/0000-0003-4845-1743, Zhao, S.S., Jani, M. orcid.org/0000-0002-1487-277X et al. (132 more authors) (2024) The influence of deprivation in the outcomes of psoriatic arthritis within the UK—utilizing Outcomes of Treatment in Psoriatic Arthritis Study Syndicate (OUTPASS) data. Rheumatology Advances in Practice, 8 (2). rkae051. ISSN 2514-1775
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Abhishek, A., Peckham, N., Pade, C. et al. (65 more authors) (2024) Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial. The Lancet Rheumatology, 6 (2). e92-e104. ISSN 2665-9913
Curry, P.D.K. orcid.org/0000-0003-0013-460X, Morris, A.P. orcid.org/0000-0002-6805-6014, Jani, M. orcid.org/0000-0002-1487-277X et al. (133 more authors) (2024) Psoriatic arthritis: the role of self-reported non-adherence, non-trough drug levels, immunogenicity and conventional synthetic DMARD co-therapy in adalimumab and etanercept response. Rheumatology Advances in Practice, 8 (1). rkae014. ISSN 2514-1775
Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587
Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736
Brady, M.C. orcid.org/0000-0002-4589-7021, Ali, M. orcid.org/0000-0001-5899-2485, VandenBerg, K. orcid.org/0000-0001-5035-9650 et al. (65 more authors) (2022) Precision rehabilitation for aphasia by patient age, sex, aphasia severity, and time since stroke? A prespecified, systematic review-based, individual participant data, network, subgroup meta-analysis. International Journal of Stroke, 17 (10). pp. 1067-1077. ISSN 1747-4930
Brady, M.C. orcid.org/0000-0002-4589-7021, Ali, M. orcid.org/0000-0001-5899-2485, VandenBerg, K. orcid.org/0000-0001-5035-9650 et al. (65 more authors) (2022) Complex speech-language therapy interventions for stroke-related aphasia: the RELEASE study incorporating a systematic review and individual participant data network meta-analysis. Health and Social Care Delivery Research, 10 (28). ISSN 2755-0060
Proceedings Paper
Rose, M.L., Ali, M., Elders, A. et al. (71 more authors) (2018) Tidier descriptions of speech and language therapy interventions for people with aphasia; consensus from the RELEASE collaboration. In: Jesus, L. and Code, C., (eds.) Aphasiology. 18th International Aphasia Rehabilitation Conference (IARC 2018), 05-07 Sep 2018, University of Aveiro, Portugal. Taylor & Francis , pp. 183-186.